Intracellular Ca2+ Signalling and Phenotype of Vascular Smooth Muscle Cells
- 9 November 2011
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 110 (1), 42-48
- https://doi.org/10.1111/j.1742-7843.2011.00818.x
Abstract
Vascular smooth muscle cells (VSMCs) express considerable plasticity in their phenotype and even can change their phenotype in vivo depending on the functional demand. In addition to contractile phenotype, VSMCs can be proliferative, migrating and/or synthetic. Importantly, contractile and non‐contractile phenotypes differ significantly in their intracellular Ca2+ signalling, which is a consequence of difference in expression of Ca2+ transport proteins. Contractile VSMCs express Ca2+ transporters, including voltage‐gated L‐type Ca2+ channels and SERCA2a pump, which maintain low resting cytosolic Ca2+ and allow dynamic changes of Ca2+ in the spatial and temporal domain, while non‐contractile VSMCs have significantly reduced voltage dependence of Ca2+ entry. These changes associated with phenotypic switch are consequences of changes in gene expression programmes, where the expression of phenotype‐specific proteins and other proteins is suppressed. Importantly, Ca2+‐sensitive transcription factors, including serum response factor, cAMP response element–binding protein and nuclear factor of activated T lymphocytes, which are important for this phenotype switch, can be activated by different types of Ca2+ signalling. Thus, different Ca2+ transport proteins not only control averaged intracellular Ca2+ but also through their differences in the character of the Ca2+ signal modulate the activity of transcription factors and thus initiate phenotype switch. The essential stimuli for phenotype switch are unknown, but intracellular Ca2+ is an important second messenger in the cell transcription programme. This article reviews the relationship between intracellular Ca2+ signalling and VSMC phenotype.Keywords
This publication has 59 references indexed in Scilit:
- SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cellsJournal of Molecular and Cellular Cardiology, 2011
- Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytesAmerican Journal of Physiology-Cell Physiology, 2009
- Ca2+handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in cultureAmerican Journal of Physiology-Cell Physiology, 2008
- The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular diseasePflügers Archiv - European Journal of Physiology, 2008
- Angiotensin-Converting Enzyme and Vascular RemodelingCirculation Research, 2007
- Excitation–Transcription Coupling in Arterial Smooth MuscleCirculation Research, 2006
- Sarco/Endoplasmic Reticulum Ca 2+ -ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the RatCirculation Research, 2005
- Molecular Determinants of Vascular Smooth Muscle Cell DiversityCirculation Research, 2005
- Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and DiseasePhysiological Reviews, 2004
- Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferationBiology of the Cell, 2004